Clinical Trials for Immunomic Therapeutics

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Immunomic Therapeutics

Clinical Trials (1)

NCT05698199
Study to Evaluate the Safety, Tolerability, Immunogenicity and Preliminary Efficacy of ITI-1001 In Patients With Newly Diagnosed Glioblastoma (GBM)
PHASE1Active, not recruiting
10 participants
Started: Aug 21, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor1 location